BG names new CEO, boosts sales for diagnostic test

05/13/2013 | Clinica (subscription required)

Paul Sohmer, who most recently led Viracor-IBT Laboratories, has been appointed to replace Eric Bouvier as president and CEO of BG Medicine. The Waltham, Mass.-based cardiovascular diagnostics firm also posted $0.8 million in sales from its BGM Galectin-3 assay during its fiscal first quarter, a rise from $0.4 million in the same period last year.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ